Home > Cashflow Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Cash Flow from Investing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Investing Activities ₹-51 Cr₹-18 Cr₹83 Cr₹-45 Cr₹-27 Cr

What is the latest Cash Flow from Investing Activities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Cash Flow from Investing Activities ratio of SYNCOM FORMULATIONS (INDIA) is ₹-51 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Investing Activities
Mar2026₹-51 Cr
Mar2025₹-18 Cr
Mar2024₹83 Cr
Mar2023₹-45 Cr
Mar2022₹-27 Cr

How is Cash Flow from Investing Activities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Cash Flow from Investing Activities % Change
Mar2026 ₹-51 Cr
Negative
Mar2025 ₹-18 Cr
Negative
Mar2024 ₹83 Cr
Positive
Mar2023 ₹-45 Cr
Negative
Mar2022 ₹-27 Cr -

Compare Cash Flow from Investing Activities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹2,094.3 Cr -10.7% 15.3% 41.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,466.0 Cr -0.8% -5.1% 6.3% Stock Analytics
DIVIS LABORATORIES ₹246,222.0 Cr -3.2% -1.4% 53.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr -1.6% -6% 32.1% Stock Analytics
CIPLA ₹107,447.0 Cr 0% -3.6% -13.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,471.0 Cr 3.1% 8.7% -1.5% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-10.7%

15.3%

41.8%

SENSEX

-0.1%

-2.3%

-10.7%


You may also like the below Video Courses